|
|
1. ASHP Guidelines on handling hazardous drugs. Développé par le ASHP Council on professional affairs et approuvé par le conseil d’administration de l’ASHP le 12 janvier 2006. Am J Health-Syst Pharm. 2006;63:1172-93.
Télécharger le document
2. Valanis B, Vollmer WM, Steele P. Occupational Exporsure to Antineoplastic Agents: Self-Reported Miscarriages and Stillbirths Among Nurses and Pharmacists. J Occu Envir Med Vol 41 No. 8, AUG 1999, 632-638.
Résumé
3. Sessink PJM, Kroese ED, van Kranen HJ, Bos RP. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health, 1995, 67:317-323.
Résumé
4. Hansen J, Olsen JH. Cancer morbidity among Danish Female pharmacy technicians. Scand J Work Environ Health, 1994; 20:22-6.
Résumé
5. Valanis B, Vollmer W, Glass A. Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing 16(4): 288-295, 1993.
Résumé
6. Skov T, Maarup B, Olsen J et al. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992; 49:855-61.
Résumé
7. Selevan SG, Lindbohm M-L, Hornug RW et al. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med. 1985; 313:1173-8.
Résumé
8. Hemminki K Kyyronen P, Lindlohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health. 1985; 39:141-7.
Résumé
9. Sotaniemi EA, Sutinen S, Arranto AJ et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983; 214:181-9.
Résumé
10. Peelen S, Roeleveld N, et al. Toxic effects on reproduction in hospital personnel. (Traduction par Interverbum, Gothenburg Suède, à partir du néerlandais).
Résumé
|
